Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Mozobil - labeled renal guidance
Product / population
Plerixafor (Mozobil), adult subcutaneous injection for stem-cell mobilization
Renal method
Cockcroft-Gault creatinine clearance, mL/min
Source revision
DailyMed SPL version 24, effective 2025-09-22; posted Sep 25, 2025
All record notes are retained here, including notes about sources not selected in this review.
Mozobil - product and source limitations
BC Cancer specifies a renal weight-based regimen at CrCl 20-50 and provides no dose below 20 or on dialysis. Check the U.S. label and local transplant protocol separately.
What to reconcile: BC Cancer specifies a renal weight-based regimen at CrCl 20-50 and provides no dose below 20 or on dialysis. Check the U.S. label and local transplant protocol separately.
At CrCl <=50 mL/min and weight <=83 kg, use 13 mg or 0.16 mg/kg once daily. For weight >83 to <160 kg, use 0.16 mg/kg once daily, maximum 27 mg/day. Verify actual weight and mobilization timing. The table stops before 160 kg and the label gives no hemodialysis dose recommendation.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
